Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCORT: Ezetimibe + Statin vs Statin Monotherapy after PCI with DES
NCT05782777Recruiting
- Sponsor
- Yonsei University
- Start
- Apr 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ezetimibe in coronary artery disease (CAD) (2 arms), sponsored by Yonsei University. Primary endpoint: Clinical efficacy of lipid lowering therapy at 3 years. Started Apr 2023; status: recruiting.
02
Drugs
ezetimibe
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05782777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05782777.